Tangerine Peel May Help Fight Cancer

Study shows no link between lycopene and reduced risk of many types of the disease

(NEWSER) - Tomatoes and lycopene, the pigment that gives them their color, do not prevent cancer, the FDA says, contradicting preliminary research. Researchers analyzed 145 studies of lycopene, tomatoes, and cancer risk and found "no credible evidence" that the vegetable wards off lung, colorectal, breast, cervical or uterine cancers, according to a report released yesterday. More»

New report focuses on disparities in funding, incidence, survival

(NEWSER) - The number of women diagnosed with lung cancer is soaring, but federal funding for research lags even though the disease is more common than cancer of the breast, prostate, and colon—combined. A new report drills down on research about women and lung cancer, sorting out findings about incidence, gender disparities, and survival. Perhaps most interesting, "all federal spending for lung cancer research amounts to $1,249 for each lung cancer death," Richard Know writes for NPR . "Spending for breast cancer research is 21 times higher—$27,480 per death." More»

Breast cancer, ovarian cancer, melanoma yield to new approaches

(NEWSER) - New treatments for cancer—breast, ovarian, and skin—raised hopes at this weekend's meeting of the American Society of Clinical Oncology in Chicago. The findings aren't enough for Robert Langreth of Forbes , who sees "serious questions about whether big drug companies may be rushing too fast." Judge for yourself.

• A single dose of radiation administered at the site of tumor removal deterred recurrence of breast cancer as well as the standard grueling course of radiation on the entire breast, the Chicago Tribune reports.

Do patents on breast, ovarian cancer genes, retard new research?

(NEWSER) - A Manhattan judge yesterday heard arguments on whether human genes should be covered by patents. A company called Myriad Genetics is being sued over its patents on two genes linked to an increased risk of breast and ovarian cancer—BRCA1 and BRCA2. The suit alleges that women's health is harmed by the patents, because, as an ACLU lawyer put it, "New forms of testing and new ways of using the gene have been inhibited." More»

New drug starves tumors of blood

(NEWSER) - A powerful new cancer drug has been developed from a fungus discovered by accident, Reuters reports. The drug, called lodamin, is dramatically effective against a range of cancers and works by starving tumors of blood, according to a new study published in the journal Nature Biotechnology. Mice infected with cancer cells were nearly cancer free within days. More»